--------------------------------------------------------------------------------

                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION

                             WASHINGTON, D.C. 20549
                         ------------------------------

                                    FORM 8-K

                                 CURRENT REPORT
                       Pursuant to Section 13 or 15(d) of
                       the Securities Exchange Act of 1934

       Date of report (Date of earliest event reported): December 1, 2006

                             ORION HEALTHCORP, INC.
             (Exact Name of Registrant as Specified in its Charter)

                          Delaware 001-16587 58-1597246
                (State or Other (Commission File (I.R.S. Employer
                     Jurisdiction of Number) Identification
                             Incorporation) Number)

                        1805 Old Alabama Road, Suite 350
                                Roswell, GA 30076
               (Address of Principal Executive Offices) (Zip Code)

                                 (678) 832-1800
              (Registrant's Telephone Number, Including Area Code)

Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions (see General Instruction A.2. below):

     |_| Written communications pursuant to Rule 425 under the Securities Act
(17 CFR 230.425)

     |_| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17
CFR 240.14a-12)

     |_| Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))

     |_| Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))

--------------------------------------------------------------------------------




Section 1   Registrant's Business and Operations

Item 1.01       Entry into a Material Definitive Agreement

         On December 1, 2006, we entered into a Credit Agreement (the "Credit
Agreement") with Wells Fargo Foothill, Inc. ("Wells Fargo"). The Credit
Agreement provides for a four year $16,500,000 senior secured credit facility
consisting of a $2,000,000 revolving loan commitment, a $4,500,000 term loan and
a $10,000,000 acquisition facility commitment. Amounts borrowed under this
facility will be secured by substantially all of our assets and a pledge of the
capital stock of our operating subsidiaries pursuant to a Security Agreement
(the "Security Agreement") with Wells Fargo.

         Amounts borrowed under this facility will bear interest at our election
at a fluctuating rate based on the prime rate or LIBOR rate. Proceeds from this
facility were used to fund our acquisitions of Rand Medical Billing, Inc. and On
Line Alternatives, Inc. and On Line Payroll Services, Inc., refinance our
existing loan facility with CIT Healthcare, LLC ("CIT"), fund certain fees and
expenses incurred in connection with the new facility and to finance our ongoing
working capital, capital expenditure, future acquisitions and general corporate
needs.

         The Credit Agreement contains certain financial covenants that require
us to maintain minimum levels of trailing twelve month EBITDA, a minimum fixed
charge coverage ratio, a maximum senior debt leverage ratio and a limitation on
annual capital expenditures and other customary terms and conditions.

         The foregoing description of the Credit Agreement does not purport to
be complete and is qualified in its entirety to the full text of the Credit
Agreement and the Security Agreement attached to this Current Report on Form 8-K
as Exhibits 10.1 and 10.2, respectively, and incorporated herein by reference.

         Additionally, on December 1, 2006, the Amendment No. 2 to our 2004
Incentive Plan (the "Amendment") was effective. The Amendment provides for (i)
an increase in the number of shares of our Class A Common Stock available for
grants under the 2004 Incentive Plan from 2,200,000 shares to 13,450,782 (an
increase of 11,250,582 shares), and (ii) an increase of the maximum number of
shares that can be granted to a participant in any calendar year from 1,000,000
to 3,000,000 shares. This amendment was approved by our stockholders at the
special meeting of the stockholders held on November 27, 2006 but was not
effective until the closing of the transactions contemplated under the Private
Placement Agreements and the filing of our Third Amended and Restated
Certificate of Incorporation which occurred on December 1, 2006.

         The foregoing description of the Amendment No. 2 to our 2004 Incentive
Plan is qualified in its entirety to the full text of the Amendment attached to
this Current Report on Form 8-K as Exhibit 10.3 and incorporated herein by
reference.

         On December 1, 2006, we also executed Amended and Restated Promissory
Notes (the "DCPS/MBS Notes") with certain of the former equity holders of
Medical Billing Services, Inc. ("MBS"), one of our wholly owned subsidiaries,
and Dennis Cain Physician Solutions, Ltd. ("DCPS") and Dennis Cain Management,
LLC ("DCM"), the general partnership interests of which are now owned by MBS,
including two of our executive officers, Dennis Cain, CEO of MBS, and Tommy
Smith, President and COO of MBS. The DCPS/MBS Notes extended the maturity date
of the subordinated promissory notes previously issued on December 15, 2004 and
April 19, 2006, respectively, from December 15, 2007 to December 15, 2008, with
principal payments beginning on December 15, 2007, and increased the interest
rate payable under the notes from 8% per annum to 9% per annum. The amounts due
under the DCPS/MBS Notes total $1,714,336 in the aggregate, which remains
unchanged from the original unsecured promissory notes. The DCPS/MBS Notes are
fully subordinate to the new credit facility from Wells Fargo. The foregoing
description of the DCPS/MBS Notes is qualified in its entirety to the full text
of the DCPS/MBS Notes, the forms of which are attached to this Current Report on
Form 8-K as Exhibit 10.10 and incorporated herein by reference.

         In 2003, one of our lenders, DVI Financial Services, Inc. ("DVI"),
announced that it was seeking protection under Chapter 11 of the United States
Bankruptcy laws. Our predecessors had loans outstanding to DVI in the form of
term loans and revolving lines of credit. In 2005 and again in 2006, we
negotiated discounts on the amounts owed to DVI and executed a new loan
agreement with U.S. Bank Portfolio Services ("USBPS"), as Servicer. Immediately
prior to December 1, 2006, there was $3,750,000 outstanding under that
agreement. On December 1, 2006, we entered into a Restructured Loan Agreement
with USBPS, as Servicer, which provides for the outstanding amount to be reduced
to $2,750,000 and for monthly payments of principal until October 1, 2013, when
the remaining amount becomes due. This indebtedness is unsecured. The
Restructured Loan Agreement is fully subordinate to the new credit facility from
Wells Fargo. The foregoing description of the Restructured Loan Agreement is
qualified in its entirety to the full text of said agreement attached to this
Current Report on Form 8-K as Exhibit 10.11 and incorporated herein by
reference.

Item 1.02       Termination of a Material Definitive Agreement

     On December 1, 2006,  we replaced  our Loan and Security  Agreement,  dated
December 15, 2004, as amended, among us, our subsidiaries and CIT (the "CIT Loan
and Security  Agreement") that provided us with a $2,750,000  secured  revolving
credit  facility with the credit  facility with Wells Fargo.  In connection with
the closing of the Credit Agreement with Wells Fargo we paid off the outstanding
balance of  $1,027,321.19  owed to CIT and  terminated the CIT Loan and Security
Agreement.  Additionally,  the Guaranty  Agreement  dated  December 15, 2004, as
amended,  issued by Brantley  Partners IV, L.P.  ("Brantley  IV") to CIT and the
Guaranty  Agreement  dated  December  15, 2004,  as amended,  issued by Brantley
Capital Corporation ("Brantley Capital") to CIT were also terminated.  This loan
facility was replaced with a new facility with Wells Fargo, as described in Item
1.01 above and incorporated herein by reference.


                                       2


Section 2   Financial Information

Item 2.01       Completion of Acquisition or Disposition of Assets

Background

         In April 2005, our board of directors initiated a strategic plan
designed to accelerate our growth and enhance our future earnings potential. The
plan focused on our strengths, which include providing billing, collections and
complementary business management services to physician practices. As part of
this plan, we completed a series of transactions involving the divestiture of
non-strategic assets in 2005 and early 2006. In addition, we redirected
financial resources and company personnel to areas that management believed
would enhance long-term growth potential. A key component of our long-term
strategic plan was the identification of potential acquisition targets that
would increase our presence in the markets we serve and enhance stockholder
value.

         As previously reported on our Current Report on Form 8-K filed with the
Securities and Exchange Commission on September 11, 2006, in furtherance of our
strategic plan, on September 8, 2006 we entered into separate stock purchase
agreements for the acquisition of all of the issued and outstanding capital
stock of (i) Rand Medical Billing, Inc. ("Rand"), and (ii) On Line Payroll
Services, Inc. ("OLP") and On Line Alternatives, Inc. ("OLA" and collectively
with OLP, "On Line"). In addition, we entered into (x) a Stock Purchase
Agreement, dated September 8, 2006 (the "Stock Purchase Agreement") with Phoenix
Life Insurance Company ("Phoenix") and Brantley IV to issue, for an aggregate
purchase price of $4,650,000, shares of a newly created class of our common
stock, Class D Common Stock, par value $0.001 per share (the "Class D Common
Stock"), which would be convertible into our Class A Common Stock and (y) a Note
Purchase Agreement, dated September 8, 2006 (the "Note Purchase Agreement," and
together with the Stock Purchase Agreement, the "Private Placement Agreements")
with Phoenix to issue, for an aggregate purchase price of $3,350,000, our senior
unsecured subordinated promissory notes due 2011 in the original principal
amount of $3,350,000, bearing interest at an aggregate rate of 14% per annum,
together with warrants to purchase shares of our Class A Common Stock. Some of
the proceeds we received upon consummation of the transactions set forth in the
Private Placement Agreements, along with proceeds from senior bank financing
with Wells Fargo and other funds available to us, were used to finance the
acquisitions of the Rand and On Line businesses.

Acquisitions

         On December 1, 2006 we completed the acquisition of all of the
outstanding capital stock of Rand. Rand is a full service billing agency,
providing medical billing exclusively for anatomic and clinical pathology
practices located in Simi Valley, California.

         Pursuant to the stock purchase agreement with Rand, which was amended
as of December 1, 2006, we paid an aggregate purchase price of $9,365,333,
subject to adjustments conditioned upon future revenue results. A portion of the
purchase price was paid in 3,314,917 shares of our Class A Common Stock (having
a value of $600,000 based on the average closing price per share of our Class A
Common Stock for the twenty day period prior to the closing of the Rand
acquisition). The remainder of the purchase price was paid in a combination of
cash and the issuance of an unsecured subordinated promissory note in the
original principal amount of $1,365,333. At the closing of the Rand acquisition,
$7,200,000 of the purchase price was paid in cash and the balance was placed in
escrow (including the unsecured subordinated promissory note and the shares of
our Class A Common Stock) pending resolution of the purchase price adjustments
and subject to claims, if any, for indemnification.


                                       3


         The second acquisition involved the purchase of all the issued and
outstanding capital stock of the On Line businesses. On Line consists of two
related companies, OLA and OLP.

         OLA is an outsourcing company providing data entry, insurance filing,
patient statements, payment posting, collection follow-up and patient refund
processing to medical practices. Most of OLA's customers are hospital-based
physician practices including radiology, neurology and emergency medicine.
Customers also include some other specialties as plastic surgery, family
practice, internal medicine and orthopaedics. All billing functions are the
responsibility of OLA, and include credentialing and accounts payable
processing. OLA also has a group of contract transcriptionists who work out of
their homes and OLA offers these services to clients as well.

         OLP provides payroll processing services to small businesses, a few of
which are also customers of OLA. OLP provides payroll services including direct
deposit, time clock interface and tax reporting to clients in Alabama, Florida,
Georgia, Louisiana, Mississippi, Tennessee and Texas.

         On December 1, 2006 we completed the acquisitions of the On Line
businesses by purchasing all of the issued and outstanding capital stock of both
OLA and OLP for an aggregate purchase price of $3,310,924, subject to
adjustments conditioned upon future revenue results. The purchase price was paid
in a combination of cash and the issuance of unsecured subordinated promissory
notes. At the closing of the On Line acquisition, $2,401,943 of the purchase
price was paid in cash and the remainder through the issuance of unsecured
subordinated promissory notes in the original principal amounts of $833,981 and
$75,000, respectively.

Private Placement Agreements

         On December 1, 2006 we also closed the transactions contemplated by the
Stock Purchase Agreement with Phoenix and Brantley IV. Pursuant to the terms of
the Stock Purchase Agreement, Phoenix purchased 15,909,003 shares of our Class D
Common Stock for $3,000,000 and Brantley IV purchased 8,749,952 shares of our
Class D Common Stock for $1,650,000.

         On December 1, 2006 we also closed the transactions contemplated by the
Note Purchase Agreement with Phoenix. Pursuant to the terms of the Note Purchase
Agreement, Phoenix purchased, for an aggregate purchase price of $3,350,000, (i)
our senior unsecured subordinated promissory notes, due 2011, in the original
principal amount of $3,350,000 and (ii) warrants to purchase 1,421,629 shares of
our Class A Common Stock. The warrants will be exercisable for five years from
the date of issuance of the warrants at $0.01 per share.

         Our senior unsecured subordinated promissory notes bear interest at the
combined rate of (i) 12% per annum payable in cash on a quarterly basis and (ii)
2% per annum payable in kind (meaning that the accrued interest will be
capitalized as principal) on a quarterly basis, subject to our right to pay such
amount in cash. The notes are unsecured and subordinated to all of our other
senior debt. Upon the occurrence and during the continuance of an event of
default the interest rate on the cash portion of the interest shall increase
from 12% per annum to 14% per annum, for a combined rate of default interest of
16% per annum. We may prepay outstanding principal (together with accrued
interest) on the note subject to certain prepayment penalties and we are
required to prepay outstanding principal (together with accrued interest) on the
note upon certain specified circumstances.


                                       4


         As of December 1, 2006, after giving effect to the Rand and On Line
acquisitions and the closing of the Private Placement Agreements, Brantley IV
owns 62,437,789 shares of our Class A Common Stock, warrants to purchase 20,455
shares of our Class A Common Stock and 8,749,952 shares of our Class D Common
Stock which are currently convertible into 8,749,952 shares of our Class A
Common Stock. As of December 1, 2006, this represents 52.9% of our voting power
on an as converted, fully diluted basis.

         Phoenix is a limited partner in Brantley IV and Brantley Partners V,
L.P and has also co-invested with Brantley IV and its affiliates in a number of
transactions. Prior to the closing of the transactions under the Private
Placement Agreements, Phoenix did not own, of record, any shares of our capital
stock. Two of our directors, Paul H. Cascio and Michael J. Finn, are affiliated
with Brantley IV and its related entities. Paul Cascio and Michael J. Finn serve
as general partners of the general partner of Brantley Venture Partners III,
L.P. ("Brantley III") and Brantley IV and are limited partners in these funds.
Neither Phoenix, Brantley IV nor Messrs. Cascio or Finn are affiliated with
Brantley Capital. The advisor to Brantley III is Brantley Venture Management
III, L.P. and the advisor to Brantley IV is Brantley Management IV, L.P.

         In connection with the closing of the Private Placement Agreements,
Phoenix purchased, for an aggregate purchase price of $3,000,000, 15,909,003
shares of Class D Common Stock, representing upon conversion 15,909,003, or
11.8%, of our outstanding Class A Common Stock as of December 1, 2006, on an as
converted, fully-diluted basis taking into account the issuance of the shares of
Class D Common Stock. In connection with the Note Purchase Agreement, Phoenix
also was issued warrants to purchase 1,421,629 shares of our Class A Common
Stock representing 1.1% of the voting power as of December 1, 2006 on an as
converted, fully diluted basis.

         On June 1, 2005, we issued two convertible subordinated promissory
notes in the amount of $1,025,000 and $225,000, respectively, to Brantley IV
(the "Brantley IV Notes") to evidence the terms of loans that were made to us by
Brantley IV on March 16, 2005 and April 19, 2005. Under the terms of the
Brantley IV Notes, the outstanding principal and interest of the Brantley IV
Notes was convertible into shares of our Class A Common Stock at a price per
share of $1.042825. On December 1, 2006, as a condition to the closing of the
Credit Agreement and the Private Placement Agreements, we issued 1,383,825
shares of our Class A Common Stock to Brantley IV upon the conversion of the
entire unpaid principal amount of, including accrued but unpaid interest, the
Brantley IV Notes.

         On December 1, 2006 we also purchased all 1,722,983 shares of our Class
B Common Stock owned by Brantley Capital for an aggregate purchase price of
$482,435 pursuant to the Stock Purchase Agreement with Brantley Capital dated
September 8, 2006. These shares of Class B Common Stock were retired in
accordance with the terms of our Third Amended and Restated Certificate of
Incorporation. In addition, in connection with the closing of the transactions
contemplated by the Private Placement Agreements all of the other holders of our
Class B and Class C Common Stock converted those shares into our Class A Common
Stock (representing 87,761,969 shares of our Class A Common Stock in the
aggregate). The acquisition and conversions were consummated simultaneous with
the closing of the transactions contemplated by the Private Placement
Agreements.

         The description of the material terms of the stock purchase agreements
with Rand and the On Line businesses and Brantley Capital referenced above is
qualified by reference to the complete text of each of the agreements included
as Exhibits 10.4, 10.5, 10.6 and 10.9 respectively to this Current Report on
Form 8-K and incorporated herein by reference. The description of the Private
Placement Agreements referenced above is qualified by reference to the complete
text of the Stock Purchase Agreement and Note Purchase Agreement included as
Exhibits 10.7 and 10.8, respectively, and incorporated herein by reference. A
copy of the Press Release announcing the closing of the acquisitions and the
private placment is attached hereto as Exhibit 99.1 and is incorporated herein
by reference.

Item 2.03       Creation of a Direct Financial Obligation or an Obligation under
                an Off-Balance Sheet Arrangement of the Registrant

         The information required by this item is included in Item 1.01 and
Exhibits 10.1, 10.2 and 99.1 of this report are incorporated herein by
reference.


                                       5


Section 3   Securities and Trading Markets

Item 3.02       Unregistered Sales of Equity Securities

         As described in Item 2.01 above and incorporated herein by reference in
connection with the closing of the acquisitions and the private placement we
issued (i) 3,314,917 shares of our Class A Common Stock to the stockholder of
Rand, (ii) 24,658,955 shares of our Class D Common Stock representing on
conversion as of December 1, 2006, 24,658,955 shares of our Class A Common Stock
to Phoenix and Brantley IV in the aggregate, (iii) warrants to purchase
1,421,629 shares of our Class A Common Stock to Phoenix, (iv) 67,742,350 shares
of our Class A Common Stock upon conversion of 8,725,487 shares of our Class B
Common Stock, (v) 20,019,619 shares of our Class A Common Stock upon conversion
of 1,437,572 shares of our Class C Common Stock, and (vi) 1,383,825 shares of
our Class A Common Stock upon conversion of the Brantley IV notes. We issued
these in reliance on Section 4(2) of the Securities Act of 1933, as amended. The
additional information required by this item is included in Items 2.01 and 3.03
and Exhibits 10.4, 10.5, 10.7, 10.8 and 99.1 and is incorporated herein by
reference.

Item 3.03       Material Modification to Rights of Security Holders

         On December 1, 2006, in connection with the closing of the transactions
contemplated by the Private Placement Agreements we filed our Third Amended and
Restated Certificate of Incorporation which (i) increased the aggregate number
of shares of our authorized capital stock from 117,000,000 shares to 370,000,000
shares, consisting of 350,000,000 shares of common stock and 20,000,000 shares
of preferred stock; (ii) specified that 300,000,000 shares of the common stock
were designated as Class A Common Stock; (iii) created a new series of common
stock designated as the Class D Common Stock consisting of 50,000,000 shares,
and (iv) eliminated the Class B and Class C Common Stock and the rights and
preferences related thereto. Our Third Amended and Restated Certificate of
Incorporation was approved by our stockholders at our special meeting of
stockholders held on November 27, 2006. As noted above in Item 2.01, as a
condition to the closing of the transactions contemplated under the Private
Placement Agreements, we purchased all of the outstanding shares of our Class B
Common Stock held by Brantley Capital Corporation and the remaining holders of
our Class B and Class C Common Stock all converted such shares into our Class A
Common Stock. As of December 1, 2006 we no longer have any Class B or Class C
Common Stock issued and outstanding.

         Except as set forth below, the Class D Common Stock, upon the filing of
our Third Amended and Restated Certificate of Incorporation has the same rights
and preferences as our Class A Common Stock:

     o    The holders of the Class D Common Stock will have  priority in certain
          distributions  made to the other holders of Common Stock.  The holders
          of the shares of Class D Common Stock (other than shares  concurrently
          being  converted into Class A Common Stock),  as a single and separate
          class, will be entitled to receive all  distributions  until there has
          been paid  with  respect  to each such  share  from  amounts  then and
          previously  distributed an amount equal to 9% per annum on the Class D
          issuance amount, without compounding, from the date the Class D Common
          Stock is first issued.  However, we will be restricted from paying any
          distribution  in cash to the  holders  of the Class D Common  Stock as
          long as the Credit  Agreement  with Wells Fargo (as  described in Item
          1.01 herein) is outstanding.

     o    In  addition  to  receiving  any  accrued  but  unpaid   distributions
          described above, the holders of the Class D Common Stock will have the
          right to receive  distributions  pari  passu  with the  holders of the
          shares of the Class A Common  Stock,  assuming  for  purposes  of such
          calculation  that each share of Class D Common Stock  represented  one


                                       6


          share  of  Class  A  Common  Stock  (subject  to  adjustment  to  such
          conversion  ratio  for  subsequent  issuances  by us of  shares of our
          capital  stock,  or rights to acquire such  shares,  for less than the
          price the  holders of the Class D Common  Stock paid for their  shares
          and for stock splits, combinations,  stock dividends and certain other
          actions as more fully specified in our certificate of incorporation).

     o    The holders of a majority of the Class D Common Stock have the ability
          to  authorize  any  payment  that  might  otherwise  be  considered  a
          distribution   for   purposes  of  our  Third   Amended  and  Restated
          Certificate  of  Incorporation  to be excluded  from the  distribution
          priority provisions described above.

     o    Each share of Class D Common  Stock will be entitled to one vote.  The
          Class D Common Stock will vote  together with all other classes of our
          Common Stock and not as a separate class, except as otherwise required
          by law or in the event of  certain  actions  adversely  affecting  the
          rights  and  preferences  of the  Class D Common  Stock as more  fully
          specified   in  our  Third   Amended  and  Restated   Certificate   of
          Incorporation.

     o    At the option of each holder of Class D Common Stock,  exercisable  at
          any time and from time to time by notice to us, each outstanding share
          of Class D Common  Stock held by such  investor  will  convert  into a
          number  of  shares  of Class A  Common  Stock  equal  to the  "Class D
          Conversion  Factor"  in effect at the time such  notice is given.  The
          Class D  Conversion  Factor  will  initially  be one  share of Class A
          Common  Stock  for each  share of Class D  Common  Stock,  subject  to
          adjustment to such conversion ratio for subsequent  issuances by us of
          shares of our capital  stock,  or rights to acquire such  shares,  for
          less than the price the  holders of the Class D Common  Stock paid for
          their shares and for stock splits,  combinations,  stock dividends and
          certain other actions as more fully specified in our Third Amended and
          Restated Certificate of Incorporation.

         The foregoing description of our Third Amended and Restated Certificate
of Incorporation does not purport to be complete and is qualified in its
entirety to the full text of the Third Amended and Restated Certificate of
Incorporation attached to this Current Report on Form 8-K as Exhibit 3.1 and
incorporated herein by reference.

Section 5   Corporate Governance and Management

Item 5.03       Amendments to Articles of Incorporation or Bylaws; Change in
                Fiscal Year

         The information required by this item is included in Item 3.03 and
Exhibit 3.1 and is incorporated herein by reference.

Section 9   Financial Statements and Exhibits

Item 9.01       Financial Statements and Exhibits

(a)  Financial Statements of Businesses Acquired

     The financial statements required by this item will be filed with the
     Securities and Exchange Commission by amendment as soon as practicable, but
     no later than 75 days after the date on which this Current Report on Form
     8-K is required to be filed.


                                       7


(b)  Pro Forma Financial Statements


     The pro forma financial statements required by this item will be filed with
     the Securities and Exchange Commission by amendment as soon as practicable,
     but no later than 75 days after the date on which this Current Report on
     Form 8-K is required to be filed.



(d)  Exhibits - The following exhibits are furnished as part of this current
report:

Exhibit      Description
-------      -----------

3.1          Third Amended and Restated Certificate of Incorporation of Orion
             HealthCorp, Inc.

10.1         Credit Agreement, dated as of December 1, 2006, by and among Orion
             HealthCorp, Inc., each of the subsidiaries identified therein,
             each of the Lenders identified therein and Wells Fargo Foothill,
             Inc., as its Arranger and Administrator Agent and Lender.*

10.2         Security Agreement, dated as of December 1, 2006, among Orion
             HealthCorp, Inc. and the other grantors identified therein and
             Wells Fargo Foothill, Inc.*

10.3         Amendment No. 2 to the Orion HealthCorp, Inc. 2004 Incentive Plan.

10.4         Stock Purchase Agreement, dated September 8, 2006, by and among
             Orion HealthCorp, Inc., Rand Medical Billing, Inc. and the
             stockholder of Rand.**

10.5         Amendment No. 1, dated December 1, 2006, to the Stock Purchase
             Agreement, dated September 8, 2006, by and among Orion HealthCorp,
             Inc., Rand Medical Billing, Inc. and the stockholder of Rand. *

10.6         Stock Purchase Agreement, dated September 8, 2006, by and among
             Orion HealthCorp, Inc., On Line Alternatives, Inc., On Line
             Payroll Services, Inc., and the shareholders of On Line
             Alternatives, Inc. and On Line Payroll Services, Inc.**

10.7         Stock Purchase Agreement, dated as of September 8, 2006, by and
             among Orion HealthCorp, Inc., Phoenix Life Insurance Company and
             Brantley Partners IV, L.P.**

10.8         Note Purchase Agreement, dated as of September 8, 2006, by and
             between Orion HealthCorp, Inc. and Phoenix Life Insurance
             Company.**

10.9         Stock Purchase Agreement, dated as of September 8, 2006, by and
             between Orion HealthCorp, Inc. and Brantley Capital Corporation.**


10.10        Forms of Amended and Restated Promissory Notes, dated as of
             December 1, 2006, by and between Orion HealthCorp, Inc. and DCPS
             Sellers and MBS Sellers

10.11        Restructured Loan Agreement, dated December 1, 2006, by and between
             Orion HealthCorp, Inc. and Lyon Financial Services, Inc. dba U.S.
             Bank Portfolio Services, as successor servicer for DVI Financial
             Services, Inc. *

99.1         Press Release issued by Orion HealthCorp, Inc. on December 4, 2006.


                                       8


---------------------
* Pursuant to Item 601(b)(2) of Regulation S-B, certain exhibits and schedules
have been omitted from this filing. The Company agrees to furnish to the
Securities and Exchange Commission on a supplemental basis a copy of any omitted
exhibit or schedule.

**Incorporated herein by reference to Exhibits 10.1 through 10.5 to our Current
Report on Form 8-K filed with the Securities and Exchange Commission on
September 11, 2006.


                                       9


                                   SIGNATURES


         Pursuant to the requirements of the Securities Exchange Act of 1934,
the Company has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.


                                            ORION HEALTHCORP, INC.


                                            By:   /s/ Stephen H. Murdock
                                               -------------------------
                                                     Stephen H. Murdock
                                                     Chief Financial Officer



Date:    December 7, 2006


                                       10


                                  EXHIBIT INDEX

Exhibit      Description
-------      -----------

3.1          Third Amended and Restated Certificate of Incorporation of Orion
             HealthCorp, Inc.

10.1         Credit Agreement, dated as of December 1, 2006, by and among Orion
             HealthCorp, Inc., each of the subsidiaries identified therein,
             each of the Lenders identified therein and Wells Fargo Foothill,
             Inc., as its Arranger and Administrator Agent and Lender.*

10.2         Security Agreement, dated as of December 1, 2006, among Orion
             HealthCorp, Inc. and the other grantors identified therein and
             Wells Fargo Foothill, Inc.*

10.3         Amendment No. 2 to the Orion HealthCorp, Inc. 2004 Incentive Plan.

10.4         Stock Purchase Agreement, dated September 8, 2006, by and among
             Orion HealthCorp, Inc., Rand Medical Billing, Inc. and the
             stockholder of Rand.**

10.5         Amendment No. 1, dated December 1, 2006, to the Stock Purchase
             Agreement, dated September 8, 2006, by and among Orion HealthCorp,
             Inc., Rand Medical Billing, Inc. and the stockholder of Rand.*

10.6         Stock Purchase Agreement, dated September 8, 2006, by and among
             Orion HealthCorp, Inc., On Line Alternatives, Inc., On Line
             Payroll Services, Inc., and the shareholders of On Line
             Alternatives, Inc. and On Line Payroll Services, Inc.**

10.7         Stock Purchase Agreement, dated as of September 8, 2006, by and
             among Orion HealthCorp, Inc., Phoenix Life Insurance Company and
             Brantley Partners IV, L.P.**

10.8         Note Purchase Agreement, dated as of September 8, 2006, by and
             between Orion HealthCorp, Inc. and Phoenix Life Insurance
             Company.**

10.9         Stock Purchase Agreement, dated as of September 8, 2006, by and
             between Orion HealthCorp, Inc. and Brantley Capital
             Corporation.**

10.10        Forms of Amended and Restated Promissory Notes, dated as of
             December 1, 2006, by and between Orion HealthCorp, Inc. and DCPS
             Sellers and MBS Sellers

10.11        Restructured Loan Agreement, dated December 1, 2006, by and between
             Orion HealthCorp, Inc. and Lyon Financial Services, Inc. dba U.S.
             Bank Portfolio Services, as successor servicer for DVI Financial
             Services, Inc. *

99.1         Press Release issued by Orion HealthCorp, Inc. on December 1, 2006.


                                       11